U.S. Online Retail and Ecommerce Stock News

NYSE:DEA
NYSE:DEAOffice REITs

Does Easterly’s Higher Revenue But Softer EPS And Maintained Dividend Reshape The Bull Case For DEA?

Easterly Government Properties, Inc. has reported its fourth-quarter 2025 results, with revenue rising to US$87.04 million while net income eased to US$4.59 million, alongside Board approval of a US$0.45 per-share quarterly dividend payable on March 19, 2026. The combination of higher revenue but lower earnings per share highlights the tension between growth and profitability as Easterly continues to support its shareholder dividend. With revenue up year over year but earnings per share...
NYSE:CUBI
NYSE:CUBIBanks

Should Customers Bancorp’s US$100 Million Buyback Shift How CUBI Investors View Its Capital Priorities?

On February 11, 2026, Customers Bancorp, Inc. announced that its Board of Directors had authorized a one-year share repurchase program of up to US$100,000,000 of its common stock. This buyback authorization highlights management’s willingness to deploy capital into reducing the share count, which can enhance per-share metrics and shareholder returns over time. Now we’ll examine how this US$100,000,000 repurchase plan may reshape Customers Bancorp’s investment narrative and capital allocation...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX F1 Deal With Apple TV Puts Live Events In Focus

IMAX and Apple TV are partnering to bring live Formula One Grands Prix to IMAX theaters across the United States. The live broadcasts follow the release of "F1: The Movie" and expand IMAX's push into real time event programming. The move broadens IMAX's content mix beyond traditional film releases, with a focus on high profile sports events. IMAX (NYSE:IMAX) is adding this Formula One deal on top of a share price of $37.81 and multi year stock returns that include 45.3% over the past year...
NYSE:NEXA
NYSE:NEXAMetals and Mining

How Atacocha’s Restart and 2026 Exploration Drive at Nexa Resources (NEXA) Has Changed Its Investment Story

Nexa Resources S.A. recently reported that operations at its Atacocha San Gerardo open pit mine in Peru, previously halted by community protests, have now gradually resumed and are progressing toward normal capacity, with an estimated production loss of about 0.9 kt of zinc that the company expects to recover over the coming months while keeping 2026 guidance unchanged. Alongside this operational stabilization, Nexa is pressing ahead with a 2026 exploration program of 59,870 meters across...
NYSE:BLX
NYSE:BLXDiversified Financial

Is Banco Latinoamericano de Comercio Exterior (BLX) Pricing In Its Trade Finance Growth Story Yet

If you are wondering whether Banco Latinoamericano de Comercio Exterior S. A is still good value after its strong run, you are not alone. The stock’s pricing now calls for a closer look at what you are actually paying for. The share price recently closed at US$49.88, with returns of 6.7% over 30 days, 13.8% year to date, 39.0% over 1 year and very large gains over 3 and 5 years at 256.8% and 336.3% respectively. This naturally raises questions about how much optimism is already reflected in...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Zoetis’ Earnings and Buybacks Could Be A Game Changer For Zoetis (ZTS)

In February 2026, Zoetis Inc. reported fourth-quarter 2025 sales of US$2,387 million and net income of US$603 million, alongside full-year 2025 sales of US$9,467 million and net income of US$2,673 million, while completing a buyback of 25,832,086 shares for US$3,559.57 million under its August 2024 authorization. Combined with 2026 guidance calling for revenue of about US$9.83–US$10.03 billion and reported diluted EPS of US$6.65–US$6.75, these results highlight how earnings growth and share...
NYSE:FDS
NYSE:FDSCapital Markets

A Look At FactSet Research Systems (FDS) Valuation After Recent Share Price Weakness

Why FactSet Research Systems has drawn fresh investor attention FactSet Research Systems (FDS) has come back on investors’ radar after a weak share price stretch, with the stock showing negative returns over the past month, past 3 months, year to date, and the past year. See our latest analysis for FactSet Research Systems. At a share price of US$195.05, FactSet Research Systems has seen momentum fade, with a 30 day share price return of 32% and a 1 year total shareholder return of 57%. This...
NYSE:FCN
NYSE:FCNProfessional Services

FTI Consulting Senior Hires Test Growth Ambitions In Complex Sectors

FTI Consulting (NYSE:FCN) has expanded its Corporate Finance & Restructuring segment with senior hires in aviation, healthcare and transaction advisory. Scott Davidson has been appointed to lead Aviation Business Transformation, focusing on aviation clients in international markets. Oussama Nicolas and Tara Makarem have been named to lead a new healthcare and life sciences offering in the Middle East. Mustapha Labassi has joined the Paris office to strengthen Transaction Services across...
NYSE:PATH
NYSE:PATHSoftware

How UiPath’s New Healthcare Agentic AI Push Will Impact UiPath (PATH) Investors

UiPath recently announced new agentic AI solutions for healthcare at the ViVE 2026 conference in Los Angeles, including tools for medical records summarization, claim denial prevention, and prior authorization to support revenue cycle management. By embedding healthcare domain expertise through partners such as Genzeon, UiPath is aiming to reduce administrative workloads for providers and tie its automation platform more directly to patient-care and financial outcomes. We’ll now examine how...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Assessing Solventum (SOLV) Valuation After Recent Share Price Weakness And Operational Streamlining Progress

Solventum stock snapshot after recent performance trends Solventum (SOLV) has caught investor attention after recent share price weakness, with the stock showing negative returns over the past week, month, and past 3 months while still posting modest annual revenue and net income growth. See our latest analysis for Solventum. The recent weakness, including a 7.57% 1 month share price decline and a 12.52% 3 month share price decline from a latest share price of $72.94, contrasts with a...
NYSE:KW
NYSE:KWReal Estate

A Look At Kennedy-Wilson (KW) Valuation After A Year Of Double Digit Shareholder Returns

Why Kennedy-Wilson Holdings (KW) is on investors’ radar today Kennedy-Wilson Holdings (KW) has drawn attention after recent share price moves, with the stock showing double digit total returns over the past year, while longer term performance has been weaker. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been firm, with a 7 day share price return of 10.21% and a 90 day share price return of 13.31%, while the 1 year total shareholder return of 29.97% contrasts with...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

The Bull Case For Microchip Technology (MCHP) Could Change Following Its New Full-Stack Edge AI Push

In February 2026, Microchip Technology expanded its edge AI offering into full-stack MCU and MPU platforms, announced an US$800 million zero-coupon senior unsecured convertible note due 2030, and participated in multiple semiconductor conferences, including the Chiplet Summit 2026 and Wolfe Research’s Auto, Auto Tech and Semiconductor Conference. The push into turnkey edge AI solutions, combining silicon, software, tools and pre-trained models, signals Microchip’s intent to move closer to...
NYSE:BBY
NYSE:BBYSpecialty Retail

Best Buy (BBY) Valuation Revisited As Tariff Uncertainty Puts Retailer Back In Focus

Tariff reset puts Best Buy (BBY) back in the spotlight A fresh 15% U.S. tariff announcement, following a Supreme Court ruling that curtailed earlier levies, has put Best Buy (BBY) on investors’ radar as a potential beneficiary if duties are later rolled back. See our latest analysis for Best Buy. Tariff headlines are landing at a time when Best Buy’s share price has been under pressure, with a 90 day share price return of a 14.73% decline and a 1 year total shareholder return of a 24.32%...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu Uber Dubai Robotaxis Test Overseas Growth And Valuation Story

Baidu (NasdaqGS:BIDU) and Uber are partnering to launch the Apollo Go autonomous ride hailing service in Dubai. The project represents Baidu's first large scale overseas deployment of its autonomous driving technology. Dubai plans to expand autonomous transportation by 2030, and this service is intended to support that city wide goal. The Dubai operation will be Baidu's first Apollo Go hub outside of China. For you as an investor looking at NasdaqGS:BIDU, this move places Baidu's core...
NYSE:IT
NYSE:ITIT

Gartner Investigation And Outlook Miss Test Investor Confidence Despite Valuation

Gartner (NYSE:IT) is under investigation by a law firm following its fourth quarter financial results. The inquiry focuses on potential securities fraud or unlawful practices linked to the company’s recent disclosures. Gartner’s 2026 outlook missed expectations, prompting fresh scrutiny of management and investor communications. The investigation and earnings update are viewed as material for current and prospective shareholders. Gartner is a research and advisory firm that sells market...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Assessing Veeva Systems (VEEV) Valuation After Recent Share Price Weakness

Veeva Systems (VEEV) is back in focus after recent trading left the stock about 18% lower over the past month and roughly 24% lower over the past 3 months, prompting fresh questions about its valuation. See our latest analysis for Veeva Systems. At a latest share price of $180.31, Veeva Systems has seen its short term momentum cool, with a 30 day share price return of 18.78% and a 90 day share price return of 23.51%. The 3 year total shareholder return of 9.21% contrasts with a 1 year total...
NYSE:GPK
NYSE:GPKPackaging

How Investors May Respond To Graphic Packaging (GPK) Weaker 2026 Outlook And Legal Investigation

In early February 2026, Graphic Packaging Holding reported weaker guidance, including an expected decline in 2026 Adjusted EBITDA, and soon after became the subject of a Pomerantz LLP investigation into potential securities law violations. These developments coincided with Atlantic Investment Management exiting its position, flat unit sales, earnings pressure, and David Einhorn significantly expanding his stake in the company. Together, the softer outlook, legal scrutiny, and contrasting...
NasdaqGS:UPBD
NasdaqGS:UPBDSpecialty Retail

Assessing Upbound Group (UPBD) Valuation After Recent Short Term Share Price Momentum

Recent performance snapshot Upbound Group (UPBD) has caught investor attention after recent share price moves, with the stock last closing at US$22.78 and showing mixed return patterns over the past year and beyond. See our latest analysis for Upbound Group. The recent 12.2% 7 day and 18.1% 30 day share price returns suggest short term momentum is building, even though the 1 year total shareholder return of 7.6% points to a weaker longer term picture. If this move has you thinking about what...
NYSE:SON
NYSE:SONPackaging

Does Sonoco Products (SON) Still Offer Value After Strong Year To Date Share Gains?

If you are looking at Sonoco Products and wondering whether the current share price offers good value, this article will walk through what the numbers are really saying about the stock. The shares most recently closed at US$56.45, with returns of 9.3% over 7 days, 16.2% over 30 days, 27.2% year to date, 26.4% over 1 year, 7.2% over 3 years and 12.8% over 5 years. This helps frame how the market has been reassessing the company over different time frames. Recent coverage of Sonoco Products...
NYSE:DX
NYSE:DXMortgage REITs

Is Dynex Capital (DX) Pricing Reflect Recent Mortgage REIT Reassessment Accurately?

If you are wondering whether Dynex Capital's current share price offers good value, you are not alone, especially with income focused investors often watching mortgage REITs closely. The stock last closed at US$14.13, with returns of 0.6% over 7 days, a 3.4% decline over 30 days, 0.4% year to date, 17.4% over 1 year, 59.2% over 3 years and 35.7% over 5 years. This raises fair questions about how that performance lines up with the underlying value. Recent coverage around Dynex Capital has...
NYSE:GATX
NYSE:GATXTrade Distributors

Assessing GATX’s Valuation After Earnings Jump Wells Fargo Railcar Deal And Higher Capital Returns

Why GATX’s latest earnings and capital moves matter for shareholders GATX (GATX) just posted double digit earnings growth for 2025, completed its large Wells Fargo railcar acquisition, and paired those results with higher dividends and a fresh $300 million buyback authorization. See our latest analysis for GATX. The recent rally has been strong, with a 1 day share price return of 5.0% and a 90 day share price return of 24.53% lifting GATX to US$198.52. The 5 year total shareholder return of...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Does ACADIA (ACAD) Have the Right Pipeline Mix as It Moves Beyond Nuplazid Dependence?

In recent days, ACADIA Pharmaceuticals drew fresh attention after Wall Street analysts reacted to updates on its neurology and rare‑disease pipeline, highlighting the company’s transition from a single‑product focus to a broader portfolio with additional development‑stage and deal‑driven assets. This shift toward a more diversified set of neurology and genetic disorder programs has become a key talking point among analysts assessing how ACADIA balances Nuplazid’s importance with new...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Applied Materials And Samsung Alliance Puts 2nm Tools In Investor Focus

Applied Materials (NasdaqGS:AMAT) has introduced new manufacturing technology aimed at 2nm and angstrom class chips. The company announced a new R&D alliance with Samsung Electronics centered on its upcoming EPIC Center in the U.S. The EPIC Center is described as the largest U.S. semiconductor process R&D facility. Applied Materials sits at the core of the chip equipment industry, supplying tools that chipmakers use to produce advanced logic and memory devices. The push toward 2nm and...
NasdaqGS:CYTK
NasdaqGS:CYTKBiotechs

Is It Too Late To Reassess Cytokinetics (CYTK) After Its 41% One Year Gain?

If you are looking at Cytokinetics and wondering whether the current share price actually reflects its underlying value, you are not alone. The stock most recently closed at US$67.94, with returns of 2.5% over 7 days, 7.1% over 30 days, 10.1% year to date and 41.1% over the past year, which naturally raises questions about what is already priced in and what is not. Recent attention around Cytokinetics has focused on its pipeline progress and regulatory milestones, which often influence how...